ArticleHistology and histopathology2025

Pinocembrin ameliorates non-alcoholic fatty liver disease by activating Nrf2/HO-1 and inhibiting the NF-κB signaling pathway.

Weina Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.